Laboratory of Palliative Medicine, Department of Social Medicine and Public Health, Medical University of Warsaw, 02-007 Warsaw, Poland.
Department of General Surgery, and Clinical Nutrition, Medical Center of Postgraduate Education, 00-416 Warsaw, Poland.
Nutrients. 2021 Mar 10;13(3):889. doi: 10.3390/nu13030889.
Home parenteral nutrition (HPN) may improve the survival in selected patients with malignant bowel obstruction. This retrospective, medical registry-based study aimed to identify clinical and laboratory markers predicting short survival, which would allow a more accurate selection of patients that would benefit from HPN in inoperative bowel obstruction. In a retrospective analysis of 114 patients receiving HPN, the median survival was 89 days after discharge home, and the three and six-month survival probability was 48% and 26%, respectively. Parenteral nutrition was provided during 98% of overall survival time and ended on a median of one day before the patient's death. Discontinuing chemotherapy, anemia, severe hypoalbuminemia, and water retention appeared correlated with survival shorter than three months. In these cases, routine initiation of HPN should be discouraged, as it may not bring any benefits to the patient. The decision on the initiation of HPN should be made along with continuing or initiating chemotherapy.
家庭肠外营养(HPN)可能会改善某些恶性肠梗阻患者的生存。这项回顾性的基于医学登记的研究旨在确定预测短期生存的临床和实验室标志物,这将有助于更准确地选择从手术性肠梗阻中受益于 HPN 的患者。在对 114 名接受 HPN 的患者进行的回顾性分析中,出院后中位生存时间为 89 天,三个月和六个月的生存率分别为 48%和 26%。肠外营养在总生存时间的 98%期间提供,并在患者死亡前一天的中位数结束。停止化疗、贫血、严重低白蛋白血症和水潴留与生存期短于三个月相关。在这些情况下,不应该鼓励常规启动 HPN,因为它可能不会给患者带来任何益处。HPN 的启动决定应与继续或开始化疗一起做出。